KR950007845A - 신장 질환용 약제학적 조성물 및 인공 신장용 투석액 - Google Patents

신장 질환용 약제학적 조성물 및 인공 신장용 투석액 Download PDF

Info

Publication number
KR950007845A
KR950007845A KR1019940022796A KR19940022796A KR950007845A KR 950007845 A KR950007845 A KR 950007845A KR 1019940022796 A KR1019940022796 A KR 1019940022796A KR 19940022796 A KR19940022796 A KR 19940022796A KR 950007845 A KR950007845 A KR 950007845A
Authority
KR
South Korea
Prior art keywords
dialysis solution
pharmaceutical composition
kidney
acceptable salt
pharmacologically acceptable
Prior art date
Application number
KR1019940022796A
Other languages
English (en)
Inventor
가즈미 오가따
다까히로 사까우에
노리꼬 사이또
사찌꼬 마쓰우라
리에 나가오
신야 오기노
Original Assignee
요시다 쇼오지
센쥬 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요시다 쇼오지, 센쥬 세이야꾸 가부시끼가이샤 filed Critical 요시다 쇼오지
Publication of KR950007845A publication Critical patent/KR950007845A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

하기 구조시의 인산 디에스테르 또는 그의 약리학적 허용가능염을 함유함을 특징으로 하는 신장 질환용 약제학적 조성물.
(상기 식에서, R1및 R2는 동일하거나 상이하며 각각 수소 원자 또는 메틸기를 나타낸다)
본 발명의 조성물은 체내에서 유리 라디칼의 형성을 저해하므로, 사구체 신염, 급성 신부전, 요독증, 아드리아마이신 신중, 푸로마이신 신중, 젠타마이신- 및 시스플라틴-유도 신장 질환, 파라콰트 및 기타의 농약에 의한 신장 손상, 및 면역 복합체 신염과 같은 여러가지 신장 질환의 예방 및 치료에 유리하게 사용될 수 있다. 또한, 본 발명의 조성물은 혈액투석 요전분중에 대하여 예방/치료 효과를 가진 인공 신장용 투석액으로서도 유용하다.

Description

신장 질환용 약제학적 조성물 및 인공 신장용 투석액
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 하기 구조식의 인산 디에스테르 또는 그의 약리학적 허용가능염을 함유함을 특징으로 하는 신장 질환용 약제학적 조성물.
    (상기 식에서, R1및 R2는 동일하거나 상이하며 각각 수소 원자 또는 메틸기를 나타낸다)
  2. 제1항에 있어서, 신장 질환이 사구체 신염, 급성 신부전, 요독중, 아드리아마이신 신중, 푸로마이신 신중, 젠타마이신-, 시스플라틴- 및 파라콰트 - 유도 신장 질환 및 면역 복합체 신염으로 구성된 군으로부터 선택된 질환인 약제학적 조성물.
  3. 제1항에 있어서, 경구용 정제 또는 주사액의 사용 형태로 제공되는 약제학적 조성물.
  4. 제1항에 정의된 인산 디에스테르 또는 그의 약리학적 허용가능염을 함유함을 특징으로 하는 인공 신장용투석액.
  5. 제4항에 있어서, 인산 디에스테르 또는 그의 약리학적 허용가능염이 0.001∼0.05(w/v)%의 농도로 함유되어 있는 인공 신장용 투석액.
  6. 제4 또는 5항에 있어서, 삼투압이 270∼300mOsm/㎏ H2O이고 pH가 6∼8인 인공 신장용 투석액.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019940022796A 1993-09-10 1994-09-09 신장 질환용 약제학적 조성물 및 인공 신장용 투석액 KR950007845A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP93-225389 1993-09-10
JP22538993 1993-09-10

Publications (1)

Publication Number Publication Date
KR950007845A true KR950007845A (ko) 1995-04-15

Family

ID=16828600

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940022796A KR950007845A (ko) 1993-09-10 1994-09-09 신장 질환용 약제학적 조성물 및 인공 신장용 투석액

Country Status (8)

Country Link
US (1) US5474992A (ko)
EP (1) EP0643969B1 (ko)
KR (1) KR950007845A (ko)
AT (1) ATE173928T1 (ko)
CA (1) CA2129509A1 (ko)
DE (1) DE69414947T2 (ko)
ES (1) ES2124348T3 (ko)
TW (1) TW298566B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101037152B1 (ko) * 2004-04-23 2011-05-26 엘지전자 주식회사 세탁기의 제어 방법

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2244535A1 (en) * 1995-05-15 2000-01-30 Avon Products, Inc. Novel uses for ascorbyl-phosphoryl-cholesterol in topical compositions
US6162450A (en) * 1995-05-15 2000-12-19 Avon Products, Inc. Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
US6436969B1 (en) 1995-09-12 2002-08-20 Kansas University Medical Center Research Institute Inc. Dialysis solutions and methods
JPH09194375A (ja) * 1996-01-17 1997-07-29 Senju Pharmaceut Co Ltd 免疫抑制作用増強剤
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
US7670491B2 (en) * 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
WO2000051987A2 (en) 1999-03-05 2000-09-08 Kansas University Medical Center Inhibitors of advanced, post-amadori glycosylation reactions
EP2052751A3 (en) * 1999-09-22 2009-06-03 Advanced Renal Technologies Use of high citrate dialysate
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
EP1420797A4 (en) 2001-07-27 2005-03-02 Vital Health Sciences Pty Ltd DERMAL THERAPY USING PHOSPHATE DERIVATIVES OF ELECTRONIC TRANSFER AGENTS
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
SE0400523D0 (sv) 2004-03-01 2004-03-01 Gambro Lundia Ab A medical solution, a method for producing said medical solution and use thereof
WO2005084678A1 (en) 2004-03-03 2005-09-15 Vital Health Sciences Pty Ltd Alkaloid formulations
SE0402507D0 (sv) 2004-10-14 2004-10-14 Gambro Lundia Ab Medicinsk lösning, förfarande för framställning och användning därav
EP1861091B1 (en) * 2005-03-03 2013-12-11 Vital Health Sciences Pty Ltd. Compounds having lipid lowering properties
ES2557475T3 (es) 2005-06-17 2016-01-26 Vital Health Sciences Pty Ltd. Un portador que comprende uno o más derivados di- y/o monofosfato de agentes de transferencia de electrones
WO2011094814A1 (en) 2010-02-05 2011-08-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
ES2829386T3 (es) 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
EP2685992A4 (en) 2011-03-15 2014-09-10 Phosphagenics Ltd AMINO-QUINOLINES AS KINASE INHIBITORS
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
CN110662733A (zh) 2016-12-21 2020-01-07 埃维科生物技术有限公司 方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25859A (en) * 1988-01-11 1991-12-02 Takeda Chemical Industries Ltd Composition for treatment of ischemic disorder
ES2058891T3 (es) * 1989-02-02 1994-11-01 Senju Pharma Co Preparacion liquida para perfusion intraocular.
JP2854631B2 (ja) * 1989-11-21 1999-02-03 千寿製薬株式会社 糖尿病合併症および老化によって引き起こされる疾患の予防・治療剤
ATE149682T1 (de) * 1991-12-04 1997-03-15 Bertin & Cie Verfahren und vorrichtung zur optischen ferndetektion eines sich in einem beobachteten raumgebiet befindenden gases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101037152B1 (ko) * 2004-04-23 2011-05-26 엘지전자 주식회사 세탁기의 제어 방법

Also Published As

Publication number Publication date
ATE173928T1 (de) 1998-12-15
TW298566B (ko) 1997-02-21
ES2124348T3 (es) 1999-02-01
US5474992A (en) 1995-12-12
EP0643969A3 (en) 1996-03-13
DE69414947T2 (de) 1999-07-08
EP0643969B1 (en) 1998-12-02
EP0643969A2 (en) 1995-03-22
CA2129509A1 (en) 1995-03-11
DE69414947D1 (de) 1999-01-14

Similar Documents

Publication Publication Date Title
KR950007845A (ko) 신장 질환용 약제학적 조성물 및 인공 신장용 투석액
TNSN01035A1 (fr) Derives d'ethers de pyrazole nouveaux, et compositions pharmaceutiques les contenant.
TNSN98036A1 (fr) Derives d'acide hexanoique nouveaux
DE69924258D1 (de) Durch einen omega-thiarest substituierte phenyl-prostaglandin-e-derivate, verfahren zu ihrer herstellung und medikamente die diese als aktiven inhaltsstoff enthalten
BR9915967A (pt) Derivados de propanolamina substituìdos por arila, proceso para sua preparação, medicamentos contendo estes compostos e seu uso
TNSN98082A1 (fr) DERIVES SUBSTITUES EN C - 4 DE 9 - DESOXO - 9a - aza - 9a HOMOERYTHROMYCINE A.
TNSN98053A1 (fr) Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions les contenant.
DE69024826D1 (de) Aza-Macrozyklen und Verfahren zu deren Herstellung
KR890016966A (ko) 신규 항바이러스제
TNSN98216A1 (fr) Derives d'acide hydrauxamique, compositions pharmaceutiques les contenant et procede pour leur preparation
TNSN01102A1 (fr) Derives de pyrazole nouveaux, procede pour leur preparation et compositions les contenant.
TNSN01048A1 (fr) Acides malonamiques et leurs derives, et compositions les contenant
YU11601A (sh) Derivati fenil jantina
TNSN99177A1 (fr) COMPOSITIONS PHARMACEUTIQUES CONTENANT DES DERIVES DE PYRIDO [1, 2-a] PYRAZINE ET PROCEDE POUR LEUR PREPARATION
TNSN99214A1 (fr) Azalides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN01131A1 (fr) Derives de phenoxybenzylamine nouveaux, procede pour leur preparation et compositions les contenant.
DE69127615D1 (de) Transformierte Erythrozyten, Verfahren zu deren Herstellung, und ihre Verwendung in pharmazeutischen Zusammensetzungen
TNSN99013A1 (fr) Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
BR9914266A (pt) Derivados de propanolamina substituìdos por heterociclos, processos para a sua preparação, medicamentos contendo estes compostos e seu emprego
KR950703527A (ko) 프로스타글란딘 유도체
BR0211586A (pt) Barra de sabão transparente e método de fabricação da mesma
TNSN99080A1 (fr) Composes azapolycycliques condenses a noyau aryle, procede pour leur preparation et compositions pharmaceutiques les contenant
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
TNSN01144A1 (fr) Derives de piperazine pontes, et compositions les contenant.
TNSN99111A1 (fr) Derives de sulfonylbenzene nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee